The Pharmaceutical Research and Manufacturers Association Gulf (PhRMAG) represents the region’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. PhRMAG is committed to partnering with policy makers that support innovative medical research, yield progress for patients today and provide hope for the treatments and cures of tomorrow in the Gulf Region.
2005 Established in the
Gulf Region
22 Biopharmaceutical
Research Companies
PhRMAG Pharmaceutical Research &
Manufactures Association Gulf
Our Code
Building Trust
The foundation of PhRMAG’s mission has been the establishment and promotion of ethical principles for the pharmaceutical industry. First enacted in 2005, adherence to the MEA Code of Promotional Practices is a binding requirement of membership at PhRMAG. Since its creation, the MEA Code has been regularly updated. The current version came into effect on November 1, 2016. The revision covers mainly new guidelines on interactions with pharmacists, and additional provisions for improvement in patient care through educational and medical programs. Key elements of the MEA Code include: promotion and its substantiation, post-marketing studies, fees for services, CME support, interactions with patient organisations, pharmaceutical company staff and information on how complaints should be handled under the Code enforcement procedure. Any healthcare professional, company or member of the general public may file a complaint reporting a breach of any provision of the MEA Code. Complaints can be reported to PhRMAG office at dream.samir@phrmag.com or info@phrmag.com
PhRMAG
MEA Code of Promotional
Practices 2016
Our Events
Biotherapeutic Workshop
May 14th 2017, MOHAP Main Office, Dubai
READ MORE
General Assembly Meeting
May 8th 2017 and November 20th 2017
PhRMAG Forum 2017
Dec 7th 2017
READ MORE